Trials / Completed
CompletedNCT03251937
Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System
VERITAS - A Study to Demonstrate the Value of Multiple Modalities Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate the value of multiple modalities and sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Spectra WaveWriter Spinal Cord Stimulator (SCS) System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spectra WaveWriter SCS System | Multiple modalities of stimulation therapy |
Timeline
- Start date
- 2018-01-09
- Primary completion
- 2019-01-09
- Completion
- 2020-03-10
- First posted
- 2017-08-16
- Last updated
- 2021-04-01
- Results posted
- 2020-03-16
Locations
15 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03251937. Inclusion in this directory is not an endorsement.